Brainomix Announces the Development of a Proprietary AI-Trained Predictive Biomarker for Idiopathic Pulmonary Fibrosis (IPF)

The imaging biomarker has demonstrated superior prognostic value compared with traditional measures, and may provide a more reliable measurement of the effects of novel therapies in clinical

Related Keywords

Elizabeth Estes ,Kostenloser Wertpapierhandel ,Prnewswire Brainomix ,Linkedin ,University Of Oxford ,Twitter ,Facebook ,Source Imaging Consortium ,Open Source Imaging Consortium ,Forced Vital Capacity ,Executive Director ,Pulmonary Fibrosis ,Brainomix ,Nnounces ,Development ,Roprietary ,Trained ,Predictive ,Biomarker ,Idiopathic ,Pulmonary ,Ibrosis ,